CN Stock MarketDetailed Quotes

300049 Inner Mongolia Furui Medical Science

Watchlist
  • 38.06
  • -0.14-0.37%
Trading Nov 15 11:24 CST
10.13BMarket Cap77.67P/E (TTM)

About Inner Mongolia Furui Medical Science Company

The company was founded in 1998 and is an enterprise focusing on liver disease treatment. The subsidiaries are located in France, Spain, Germany, the United States, Hong Kong and other major provincial capitals. The company was listed on the Shenzhen Stock Exchange GEM in 2010. The company's main business is pharmaceutical production and sales, research and development and sales of diagnostic equipment, and medical services. The company's main products: compound turtle liver tablets, FibroScan series liver fibrosis diagnostic instruments, managed medical strategies, pediatric healthcare management. Corporate honors: “2019 Corporate Social Responsibility Industry Model Award” at the 9th China Charity Festival, “2020 Charity Group Award Project Award” at the 10th China Charity Festival, “Companies Listed on the IR Interactive Activity List” for A-share listed companies in 2018, etc.

Company Profile

Short Name-A福瑞股份
Symbol-A300049
Company NameInner Mongolia Furui Medical Science Co.,Ltd.
Listing DateJan 20, 2010
Issue Price28.98
Shares Offered19.00M share(s)
FoundedDec 26, 2001
Legal Representativeguanyi wang
General Managerguanyi wang
Secretaryxiuzhen sun
Accounting FirmDahua Certified Public Accountants (Special General Partnership)
Legal CounselBeijing Jincheng Tongda Law Firm
Employees229
Phone010-84683855
Office Address7th Floor, Block 2, Kunsha Center, No. 16 Xinyuanli, Chaoyang District, Beijing
Zip Code100027
Registered AddressNo. 103 Jiefang Road, Jining District, Ulanqab City, Inner Mongolia Autonomous Region
Fax010-84683766
Emaildshbgs@fu-rui.com
Business License150000000005321
BusinessProduction and sale of Chinese and Western biochemicals. Sales of Class II and Class III medical devices. Software development, information technology consulting services, own real estate business activities, other professional technical services, technology promotion services. The company may adjust its business scope and mode of operation in due course in accordance with the provisions of relevant laws and regulations according to its own development capabilities and business needs, and establish branches and offices at home and abroad.

Company Executives

  • Name
  • Position
  • Salary
  • guanyi wang
  • Chairman, Directors, General Manager, Nomination Committee Members, Chairman of the Strategy Development Committee
  • 300.00K
  • yong yang
  • Directors, Member of the Strategy Development Committee, Audit Committee Member
  • 783.00K
  • lijuan deng
  • Directors, Deputy General Manager, Member of the Human Resources and Remuneration Committee, Member of the Strategy Development Committee
  • 1.02M
  • jinlong guo
  • Independent Directors, Member of the Human Resources and Remuneration Committee, Nomination Committee Members, Chairman of the Audit Committee
  • 60.00K
  • peng guo
  • Independent Directors, Audit Committee Member, Chairman of the Nomination Committee, Chairman of the Human Resources and Remuneration Committee
  • 60.00K
  • xiuzhen sun
  • Board Secretary
  • 423.60K
  • dawei niu
  • Chairman of the Supervisory Board, Employee Supervisors
  • --
  • hao chen
  • Auditors
  • --
  • zhiguo shen
  • Deputy General Manager, Chief Financial Officer
  • --
  • liqun wang
  • Deputy General Manager
  • 357.70K
  • ru wang
  • Employee Supervisors
  • 86.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data